The effect of T2D on insulin receptor expression in liver and skeletal muscles has not been extensively studied but the available evidence suggests that there is no cell surface receptor deficit in people with obesity and T2D compared with obese control participants [120,121,132]. This evidence concerns the gene CD177 and type 2 diabetes mellitus.